(IN BRIEF) WACKER has launched a new Contract Research Services platform designed to support biotech and biopharma companies developing nucleic acid-based medicines, including RNA therapies, plasmid DNA technologies and lipid nanoparticle formulations. Operating from the company’s Biotechnology Center in Munich, … Read the full press release →
Posted in Business, Chemicals, Economy, Financial, Germany, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology
Tagged advanced therapeutics, biopharma, biotechnology, biotechnology innovation, biotechnology research, circular RNA, clinical manufacturing, Contract Research Services, crs, drug development, gene therapy, GMP manufacturing, lipid nanoparticles, LNPs, mRNA, Munich, nucleic acid medicines, pDNA, pharmaceutical industry, plasmid DNA, PLASMITEC®, RNA engineering, RNA therapeutics, saRNA, self-amplifying RNA, SRTD Biotech GmbH, vaccine development, WACKER, Wacker Biotech, WACKER expands advanced therapeutics capabilities with integrated Contract Research Services offering, WACKER expands biotechnology services with new Contract Research Services platform for nucleic acid medicines, WACKER launches new biotechnology research platform for RNA and nucleic acid therapeutic development, WACKER strengthens global biotechnology services with scalable nucleic acid development solutions
Researchers from LIH’s Cardiovascular Research Unit and international collaborators published an article in the number one cardiology journal, Journal of the American College of Cardiology, in September 2016. They identified a circular RNA that can predict patient outcome after heart … Read the full press release →
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
